Skin regeneration with fibroblast growth factor 2 released from heparin-conjugated fibrin

Biotechnol Lett. 2011 Apr;33(4):845-51. doi: 10.1007/s10529-010-0492-5. Epub 2010 Dec 8.

Abstract

Fibroblast growth factor 2 (FGF2) stimulates skin wound healing but does long-term delivery of FGF2 enhance skin regeneration compared to short-term delivery? Heparin-conjugated fibrin (HCF) was used as a vehicle for long-term delivery of FGF2. Fibrin, HCF, FGF2-loaded fibrin, and FGF2-loaded HCF were implanted into full-thickness skin defects of mice. The neoepidermis thickness was significantly larger in the FGF2-loaded HCF group than in the other groups, except for the FGF2-loaded fibrin group. Suprabasal cytokeratin differentiation in squamous neoepithelium was greatest in the FGF2-loaded HCF group. The enhanced skin regeneration accompanying the long-term delivery of FGF2 could be mediated, at least partially, by enhanced neovascularization and cell proliferation in the neodermis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Proliferation / drug effects
  • Fibrin* / chemistry
  • Fibrin* / metabolism
  • Fibroblast Growth Factor 2 / metabolism
  • Fibroblast Growth Factor 2 / pharmacology
  • Heparin* / chemistry
  • Heparin* / metabolism
  • Immunohistochemistry
  • Mice
  • Regeneration / drug effects*
  • Skin / drug effects*
  • Wound Healing

Substances

  • Fibroblast Growth Factor 2
  • Fibrin
  • Heparin